Last reviewed · How we verify
Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
To evaluate the superiority of cognitive behavioral therapy using the Aurora® digital medical device + conventional drug treatment, compared to conventional drug treatment alone, in reducing anxiety symptoms, as assessed by the change in the GAD-7 scale at 12 weeks of treatment, relative to baseline.
Details
| Lead sponsor | Psicofarma, S.A. De C.V. |
|---|---|
| Phase | PHASE3 |
| Status | RECRUITING |
| Enrolment | 162 |
| Start date | Sun Mar 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Jul 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- General Anxiety Disorder
Interventions
- App AURORA (Digital Therapy) + conventional treatment
- Pharmacological conventional treatment
Countries
Mexico